EIT Acquired by J&J, September 2018

Written on September 21, 2018 at 12:15 pm, by

EIT can now be found in the spine portfolio of Depuy Synthes, a Johnson & Johnson company. Congrats to the entire EIT team and Ortho Sales Partners!

Emerging Implant Technologies’ EIT Cellular Titanium (w/o graft window) – greater primary stability, less subsidence, similar fusion results to PEEK with autograft

Written on May 14, 2018 at 5:58 pm, by

  Here are six things to know. 1. EIT is a German medical device manufacturer focused on creating spinal implants with additive manufacturing. 2. The company’s implants are made of 3D-printed EIT Cellular Titanium with a porosity of 80 percent. 3. The EFFECT trial is a prospective controlled trial evaluating the radiological results of 50

  Read More

PacHealth Partners now distributing Minuteman G3R

Written on April 3, 2018 at 11:07 am, by

Minuteman G3R, an elegant new HA coated implant by Spinal Simplicity. Stable, solid fusion posteriorly via lateral approach. Features and Benefits Minimally invasive alternative to traditional pedicle screws and other spinous process plates. Low Profile with 12mm removable portion of the implant body Lateral MIS approach eliminates the lateral dissection of the healthy tissue (neural

  Read More


Written on November 17, 2017 at 12:29 am, by

Surgentec brings a new advancement to the bone graft delivery arena with the Graftgun®. Details on the Biologics page of Our Graft Delivery System (GDS®) is designed to allow for universal, quick, and accurate bone graft delivery to a surgical site without the problems of a traditional funnel. Its patented, controlled release method is

  Read More

Corin completes Joint Venture Agreement with Ossis to Deliver Patient Specific Implants

Written on November 1, 2017 at 2:43 pm, by

Corin, a global orthopaedic manufacturer and leader in functional implant positioning has announced a joint venture agreement with Ossis, a New Zealand-based implant maker. With more than 15 years clinical history Ossis is one of the leaders in design and manufacturing of personalised solutions for complex revision surgery and tumour resection. Since 2007 Ossis has

  Read More

Cerapedics Announces Publication of Two-Year IDE Study Follow-Up Data on i-FACTOR™ Bone Graft in the Cervical Spine

Written on September 20, 2017 at 7:40 am, by

Cerapedics, a privately-held orthobiologics company, today announced the publication of two-year follow-up data from an FDA Investigational Device Exemption (IDE) clinical trial of i-FACTOR™ Peptide Enhanced Bone Graft. The results published in the peer reviewed journal Neurosurgery show i-FACTOR Bone Graft is statistically superior in overall clinical success to autograft in anterior cervical discectomy and fusion (ACDF)

  Read More

Oxford Finance Provides $20 Million Senior Debt Facility to Orthobiologics Company Cerapedics Inc. (i-FACTOR)

Written on August 25, 2017 at 8:10 pm, by

ALEXANDRIA, Va. and WESTMINSTER, Colo., April 19, 2017 /PRNewswire/ — Oxford Finance LLC (“Oxford”), an industry-leading specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $20 million senior secured term loan with Cerapedics Inc. (“Cerapedics”) a privately-held orthobiologics company engaged in the development and commercialization of bone graft substitute products

  Read More

EIT Emerging Implant Technologies Acquires 22 Patents for 3D Printed Expandable Cage Technology Based on Living Hinges from Dr. Morgan Lorio

Written on August 25, 2017 at 5:39 pm, by

Emerging Implant Technologies GmbH (EIT), a German medical device manufacturer exclusively focused on creating innovative technologies for spinal applications by utilizing additive manufacturing (“3D-Printing”), today announced the acquisition of a full patent portfolio of 22 issued and pending patents for 3D printed expandable spinal fusion cages based on living hinges from Morgan P. Lorio, MD.

  Read More

EIT Emerging Implant Technologies Announces 510(k) Approval from the FDA for Full 3D Printed Cage Portfolio

Written on August 25, 2017 at 5:32 pm, by

Emerging Implant Technologies GmbH (EIT), a German medical device manufacturer exclusively focused on creating innovative technologies for spinal application by utilizing additive manufacturing, announces that it has received full approval from the FDA to commercialize its spinal interbody product offerings for ALIF, TLIF, PLIF and Cervical procedures. EIT Cellular Titanium® is a porous titanium structure

  Read More


Written on August 25, 2017 at 5:29 pm, by

WAYNE, Pa., August 15, 2017 – Camber Spine Technologies announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its SPIRA™ Open Matrix ALIF device, a unique, interbody fusion implant consisting of spiral support arches and Surface by Design™ technology.  This clearance marks Camber’s tenth line of

  Read More